Study Reveals Weight Gain Concern Among Breast Cancer Survivors
Recent research presented at the Endocrine Society’s ENDO 2024 annual meeting reveals a concerning trend among breast cancer survivors. Nearly one in five survivors may experience weight gain exceeding 10% of their body weight post-treatment. This weight gain not only increases the risk of cancer recurrence but also raises the likelihood of cardiovascular diseases. Experts emphasize the importance of daily physical activity in helping women maintain a healthy weight following breast cancer treatment, highlighting the need for continued support and awareness in addressing post-treatment issues.
New Study Shows Tapering GLP-1 Drugs May Prevent Rebound Weight Gain
New research suggests that slowly tapering off GLP-1 drugs like Ozempic and Wegovy may help prevent rebound weight gain. A recent study revealed that patients who gradually reduced their dosage to zero were able to successfully maintain their weight. This innovative approach involved drug tapering and personalized holistic health coaching, emphasizing lifestyle modifications and behavioral changes for sustained weight loss.